Approval of Drugs With Unmet Trial End Points-In Reply.

•  
• Overview
•  
• Identity
•  
• Additional Document Info
•  
• View All
•  

Overview

authors

• Johnston, James L
• Joseph S. Ross, MD, MHS
• Ramachandran, Reshma

publication date

• August 1, 2023

published in

• JAMA internal medicine  Journal

has subject area

• Antineoplastic Agents
• Drug Approval
• Humans
• United States
• United States Food and Drug Administration

Identity

Digital Object Identifier (DOI)

• https://doi.org/10.1001/jamainternmed.2023.2240

PubMed ID

• 37307009

Additional Document Info

start page

• 889

end page

• 890

volume

• 183

issue

• 8